Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literature

Annals of Oncology

Volumn 8, Issue 3, 1997, Pages 227-234

  Reni, M ^a   Ferreri, A J M ^a   Garancini, M P ^a   Villa, E ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

brain neoplasms; chemotherapy; combined treatment; extranodal lymphomas; primary central nervous system lymphoma; radiotherapy

Indexed keywords

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; METHOTREXATE; NITROSOUREA DERIVATIVE;

AGE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL TRIAL; HUMAN; IMMUNOCOMPETENCE; INTRATHECAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IMMUNOCOMPETENCE; INFANT; INJECTIONS, SPINAL; LYMPHOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; SURVIVAL RATE;

EID: 0030897452     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008201717089     Document Type: Review

References (75)

1. Hochberg F, Miller D. Primary central nervous system lymphoma. J Neurosurg 1988; 68: 835-53.
2. Eby NL, Grufferman S, Flannelly CM et al. Increasing incidence of primary brain lymphoma in the US. Cancer 1988: 62: 2461-5.
3. Hardwidge C, Diengdoh JV, Husband D et al. Primary cerebral lymphoma a clinico-pathologic study. Clin Neuropathol 1990; 9: 217-223.
4. Miller DC, Hochberg FH, Harris NL et al. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. Cancer 1994; 74: 1383-97.
5. Henry JM, Heffner Jr, Dillard SH et al. Primary malignant lymphomas of the nervous system. Cancer 1974; 34: 1293-302.
6. Sagerman RH, Cassady JR, Chang CH. Radiation therapy for intracranial lymphoma. Radiology 1967; 88: 552-4.
7. Littman P, Wang CC. Reticulum cell sarcoma of the brain: A review of the literature and a study of 19 cases. Cancer 1975; 35: 1412-420.
8. Rampen FHJ, van Andel JG, Sizoo W et al. Radiation therapy in primary non-Hodgkin's lymphomas of the CNS, Eur J Cancer 1980; 16: 177-84.
9. Bogdahn U, Bogdahn S, Mertens HG et al. Primary non-Hodgkin's lymphomas of the CNS. Acta Neurol Scand 1986; 73: 602-14.
10. Murray K, Kun L, Cox J. Primary malignant lymphoma of the central nervous system. J Neurosurg 1986: 65: 600-7.
11. Pollack IF, Dade Lunsford L, Flickinger JC et al. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 1989; 63: 939-47.
12. Hayakawa T, Takakura K. Abe H et al. Primary central nervous system lymphoma in Japan. A retrospective, co-operative study by CNS-Lymphoma Study Group in Japan. J Neurooncol 1994; 19: 197-215.
13. Nelson DF, Martz KL, Bonner H et al. Non-Hodgkin's lymphomas of the brain: Can high-dose, large volume radiation therapy improve survival? Report on a prospective trial by the radiation therapy oncology group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992; 23: 9-17.
14. DeAngelis LM, Yahalom J, Heinemann MH, Primary CNS lymphoma: Combined treatment with chemotherapy and radiotherapy. Neurology 1990; 40: 80-7.
15. Shibamoto Y, Tsutsui K, Dodo Y et al. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy. Cancer 1990; 65: 1907-12.
16. Chamberlain MC, Levin VA. Adjuvant chemotherapy for primary lymphoma of the central nervous system. Arch Neurol 1990; 47: 1113-6.
17. Socié G, Piprot-Chauffat C, Schlienger M et al. Primary lymphoma of the central nervous system: An unresolved therapeutic problem. Cancer 1990; 65: 322-6.
18. Glass J, Gruber ML, Cher L et al. High-dose methotrexate therapy of primary brain lymphoma. J Neurosurg 1989; 70: 190-4.
19. Kawakami Y, Tabuchi K, Ohnishi K et al. Primary central nervous system lymphoma. J Neurosurg 1985; 62: 522-7.
20. Boiardi A, Silvani A, Valentini S et al. Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data. J Neurol 1993; 241: 96-100.
21. Loeffler JS, Ervin TJ, Mauch P et al. Primary lymphomas of the central nervous system: Patterns of failure and factors that influence survival. J Clin Oncol 1985; 3: 490-4.
22. Ashby MA, Bowen D, Bleehen NM et al. Primary lymphoma of the central nervous system: Experience at Addenbrooke's Hospital, Cambridge. Clin Radiol 1988; 39: 173-81.
23. Berry MP, Simpson WJ. Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radial Oncol Biol Phys 1981; 7: 55-9.
24. Blay JY, Lasset C, Carrie C et al. Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring. Br J Cancer 1993; 67: 1136-41.
25. Brada M, Dearnaley D, Horwich A et al. Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 1990; 18: 787-92.
26. Braus DF, Schwechheimer K, Muller-Hermelik HK et al. Primary cerebral malignant non-Hodgkin's lymphomas: A retrospective clinical study. J Neurol 1992; 239: 117-24.
27. DeAngelis L, Yahalom J, Thaler HT et al. Combined modality therapy for primary CNS lymphoma. J Clin Oncol 1992; 10: 635-43.
28. Di Marco A, Rosta L, Campostrini F et al. The role of radiation therapy in the management of primary non-Hodgkin's lymphomas of the central nervous system: Clinical study of 10 cases. Tumori 1986; 72: 565-73.
29. Dorreen MS, Ironside JW, Bradshaw JD et al. Primary intracerebral lymphoma: Clinicopathological analysis of 14 patients presenting over a 10-year period in Sheffield. Q J Med New Series 1988; 67 (253): 387-404.
30. Ferreri AJM. Reni M, Bolognesi A et al. Combined therapy for primary central nervous system lymphoma in immunocompetent patients. Eur J Cancer 1995; 31A (12): 2008-12.
31. Frank G, Ferracini R, Spagnolli F et al. Primary intracranial lymphomas. Surg Neurol 1985; 23: 3-8.
32. Freeman CR, Shustik C, Brisson ML et al. Primary malignant lymphoma of the central nervous system. Cancer 1986; 58: 1106-11.
33. Gonzalez D, Scuster-Uitterhoeve LJ. Primary non-Hodgkin's lymphoma of the central nervous system. Results of radiotherapy in 15 cases. Cancer 1983; 51: 2048-52.
34. Helle TL, Britt RH, Colby TV. Primary lymphoma of the central nervous system. J Neurosurg 1984; 60: 94-103.
35. Miller DC, Hochberg FH, Harris NL et al. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. Cancer 1994; 74: 1383-97.
36. Krogh-Jensen M, d'Amore F, Jensen MK et al. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Ann Oncol 1994; 5: 349-54.
37. Lachance DH, Brizel DM, Gockerman JP et al. Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: Short duration response and multifocal intracerebral recurrence preceding radiotherapy. Neurology 1994; 44: 1721-7.
38. Letendre L, Banks PM, Reese DF et al. Primary lymphoma of the central nervous system. Cancer 1982; 49: 939-43.
39. Ling SM, Roach M, Larson DA et al. Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California. San Francisco. Cancer 1994; 73: 2570-82.
40. Mackintosh FR, Colby TV, Podolsky WJ et al. Central nervous system involvement in non-Hodgkin's lymphoma: An analysis of 105 cases. Cancer 1982; 49: 586-95.
41. Mc Laughlin P, Velasquez WS, Redman JR et al. Chemotherapy with dexamethasone, high-dose cytarabine. and cisplatin for parenchymal brain lymphoma. J Natl Cancer Inst 1988; 80: 1408-12.
42. Mendenhall NP, Thar TL, Agee OF et al. Primary lymphoma of the central nervous system: Computerized tomography scan characteristics and treatment results for 12 cases. Cancer 1983; 52: 1993-2000.
43. Michalski JM, Garcia DM, Kase E et al. Primary central nervous system lymphoma: Analysis of prognostic variables and patterns of treatment failure. Radiology 1990; 176: 855-60.
44. Morgello S, Maiese K, Petito CK. T-cell lymphoma in the CNS: Clinical and pathologic features. Neurology, 1989: 39: 1190-6.
45. Neuwelt EA, Goldman DL, Dahlborg SA et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservation of cognitive function. J Clin Oncol 1991; 9: 1580-90.
46. Pittman KB, Olweny CLM, North JB et al. Primary central nervous system lymphoma. Oncology 1991; 48: 184-7.
47. Remick SC, Diamond C, Migliozzi JA et al. Primary central nervous system lymphoma in patients with and without the Acquired Immune Deficiency Syndrome. A retrospective analysis and review of the literature. Medicine 1990: 69: 345-60.
48. Sagerman RH, Collier CH, King GA. Radiation therapy of microgliomas. Radiology 1983; 149: 567-70.
49. Sarazin M, Ameri A, Monjour A et al. Primary central nervous system lymphoma: Treatment with chemotherapy and radiotherapy. Eur J Cancer 1995; 31A (12): 2003-7.
50. Selch MT, Shimizu KT, De Salles AF et al. Primary cenral nervous system lymphoma. Am J Clin Oncol 1994; 17(4): 286-93.
51. Spaun E, Midholm S, Pedersen NT et al. Primary malignant lymphoma of the CNS. Surg Neurol 1985; 24: 646-50.
52. Tomlinson FH, Kurtin PJ, Suman VJ et al. Primary intracerebral malignant lymphoma: A clinicopathological study of 89 patients. J Neurosurg 1995; 82: 558-66.
53. Uematsu M, Kondo M. Dokiya T et al. Primary non-AIDS related brain lymphoma. Patterns of failure following radiotherapy. Acta Oncol 1992; 31 (5): 551-4.
54. Vakili ST, Muller J, Shidnia H et al. Primary lymphoma of the central nervous system: A clinicopathologic analysis of 206 cases. J Surg Oncol 1986; 33: 95-102.
55. Watne K, Scott H, Hager B et al. Primary malignant lymphoma of the brain. A report of 24 cases from the Norwegian Radium Hospital. Acta Oncol 1992; 31 (5): 545-50.
56. Woodman R, Shin K, Pineo G. Primary non-Hodgkin lymphoma of the brain: A review. Medicine 1985; 64: 425-30.
57. Yasunaga T, Takahashi M, Uozumi H et al. Radiation therapy of primary malignant lymphoma of the brain. Acta Radiol Oncol 1986; 25: 23-8.
58. Kaplan EL, Meier P. Non-parametric estimations from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
59. Peto R, Pike MC. Conservatism of the approximation (O-E)/E in the log-rank test for survival data or tumor incidence data. Biometrics 1973; 29; 579-83.
60. Cox DR. Regression models and life-tables. J R Stat Soc 1972 34: 187-220.
61. O'Neill BP, O'Fallon JR, Earle JD et al. Primary central nervous system non-Hodgkin's lymphoma: Survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys 1995; 33 (3): 663-73.
62. Schultz C, Scott C, Sherman W et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine and dexamethasone for primary CNS lymphomas: Initial report of Radiation Therapy Oncology Group Protocol 88-06. J Clin Oncol 1996: 14 (2): 556-64.
63. Jellinger K, Kothbauer P, Weiss R et al. Primary intracranial malignant lymphomas. A fine structural, cytochemical and CSF immunological study. Clin Neurol Neurosurg 1979; 81: 173-81.
64. Cox JD, Koehl RH, Turner WM. Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin's malignant lymphoma). Radiology 1974; 112: 179-85.
65. Jellinger KA, Paulus W. Primary central nervous system lymphoma - an update. J Cancer Res Clin Oncol 1992; 119: 7-27.
66. DeAngelis LM. Primary central nervous system lymphoma. Principles and Practice of Oncology (updates Vol. 8) 1994; 6 (11): 1-13.
67. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993; 119: 1093-104.
68. Ott RJ, Brada M, Flower MA et al. Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 1991; 27: 1356-61.
69. Stewart DJ, Russell N, Atack EA et al. Cyclophosphamide, doxorubicin, vincristine and dexamethasone in the treatment of bulky CNS lymphoma. J Neurooncol 1984; 2: 289.
70. Schaumburg HH, Plank CR, Adams RD. The reticulum cell sarcoma-microglioma group of brain tumours. A consideration of their clinical features and therapy. Brain 1972; 95: 199-212.
71. Pitman SW, Frei E. Weekly methotrexate-calcium leucovorin rescue: Effect of alkalinization on nefrotoxicity: pharmacokinetics in the CNS; and the use in CNS non-Hodgkin's lymphoma. Cancer Treat Rep 1977; 61: 695-701.
72. Slevin ML, Piall EM, Aherne GW et al. Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid. J Clin Oncol 1983; 1: 546-51.
73. Fine HA. Treatment of primary central nervous system lymphoma: Still more questions than answers. Blood 1995; 86 (8): 2873-5.
74. Hill BT, Shellard SA, Hosking LK. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cisdiammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractioned x-irradiation. Int J Radiat Oncol Biol Phys 1990; 19: 75-83.
75. Geyer JR, Taylor EM, Milstein JM. Radiation, methotrexate and white matter necrosis: Laboratory evidence for neural radioprotection with pre-irradiation methotrexate. Int J Radial Oncol Biol Phys 1988; 15: 373-5.